Dubber Corporation launches A$25m equity raising to secure growth ambitions

Pallavi Madhiraju- October 11, 2024 0

In a significant financial move, Dubber Corporation Limited has announced a A$25 million equity raising, fully underwritten to secure the company's growth trajectory and fuel ... Read More

Echo IQ’s EchoSolv AS gains FDA approval—AI-powered solution to tackle underdiagnosed Aortic Stenosis

Pallavi Madhiraju- October 11, 2024 0

Sydney-based AI medical technology company, Echo IQ Limited, has achieved a significant breakthrough with the US Food and Drug Administration (FDA) clearance for its EchoSolv ... Read More

Audeara secures $570,000 Clinico order for co-developed hearing earbuds

Pallavi Madhiraju- October 8, 2024 0

Audeara Limited, a prominent hearing health innovator, announced a significant purchase order from Clinico Inc., Taiwan's leading hearing aid retailer, valued at $570,000. The order ... Read More

Neuren Pharmaceuticals advances NNZ-2591 for Phelan-McDermid syndrome to Phase 3 clinical trial

Pallavi Madhiraju- October 7, 2024 0

Neuren Pharmaceuticals has secured approval from the United States Food and Drug Administration (FDA) to progress into the first-ever pivotal Phase 3 clinical trial of ... Read More

Chimeric Therapeutics announces breakthrough AML response with CHM CORE-NK in Phase 1B trial

Pallavi Madhiraju- October 7, 2024 0

Chimeric Therapeutics has reported a significant milestone in its ongoing clinical trials, wherein a patient diagnosed with Acute Myelogenous Leukemia (AML) has exhibited a complete ... Read More

Immuron Limited reveals key findings from NMRC study, eyes future collaboration with U.S. DoD

Pallavi Madhiraju- October 6, 2024 0

Immuron Limited has announced the results of a Campylobacter human infection model study conducted by the U.S. Naval Medical Research Command (NMRC). The Melbourne-based biopharmaceutical ... Read More

Realty ONE Group partners with RMA Global to empower 20,000 agents

Pallavi Madhiraju- September 30, 2024 0

RMA Global Limited (ASX: RMY) has unveiled an exciting new partnership with Realty ONE Group, marking a significant milestone for both companies. This strategic agreement ... Read More

Noxopharm bags new funding to fuel game-changing cancer treatments

Pallavi Madhiraju- September 29, 2024 0

Noxopharm Limited, an Australian biotech powerhouse, has successfully raised A$2.1 million in funding through the issuance of convertible notes to sophisticated investors. This funding will ... Read More

Step One founder Greg Taylor sells stake amid investor surge

Pallavi Madhiraju- September 26, 2024 0

Step One Clothing Limited, the leading online direct-to-consumer innerwear brand, recently announced a significant development involving its founder and CEO, Greg Taylor. Taylor has agreed ... Read More

Pharma breakthrough! BioIntelect to revolutionise trials using Opyl’s cutting-edge tech

Pallavi Madhiraju- September 25, 2024 0

In a landmark collaboration, Opyl Limited announced a new six-month agreement with BioIntelect, a renowned Clinical Research Organisation (CRO) and strategic consulting firm in the ... Read More